Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study
Debadatta Nayak, Juhi Gupta, Anupriya Chaudhary, Krishna Gopal Singh, Abhijeet Deshmukh, Deblina Das, Abhishek Saha, Deepak Kumar, Ashwini Kumar, Ajay Goenka, Shivendra Kumar Mishra, Sanjay Gupta, Anil Khurana
Abstract
• A randomized, placebo-controlled trial of adjunct homeopathy with standard of care for COVID-19 was conducted on 300 patients. • Primary outcome on total symptom score measured over 10 days decreased significantly favoring Standard of care + Homeopathy. • Recovery was earlier in Standard of care + Homeopathy group by 02 days showing the added benefits of homeopathy. • Resolution of fever was 20 h earlier in Standard of care + Homeopathy. • Arsenicum album , Bryonia alba and Phosphorus were the most frequently prescribed medicines.
Topics & Concepts
HomeopathyMedicinePlaceboAdjunctStandard of careRandomized controlled trialCoronavirus disease 2019 (COVID-19)Alternative medicineTraditional medicineInternal medicinePathologyLinguisticsPhilosophyDiseaseInfectious disease (medical specialty)Complementary and Alternative Medicine StudiesLong-Term Effects of COVID-19Vitamin C and Antioxidants Research